Jun 25, 2025 09:15AM
Jun 25, 2025 09:15AM
May 21, 2025 09:03AM
May 21, 2025 09:00AM
May 20, 2025 09:23AM
May 20, 2025 09:15AM
May 6, 2025 09:22AM Petros Pharmaceuticals (PTPI) Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
May 6, 2025 09:20AM
May 1, 2025 09:24AM
May 1, 2025 09:20AM
Apr 29, 2025 09:23AM
Apr 29, 2025 09:20AM
Mar 20, 2025 09:17AM
Mar 20, 2025 09:15AM Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
Feb 25, 2025 09:21AM
Feb 25, 2025 09:20AM
Feb 18, 2025 09:30AM
Feb 18, 2025 09:25AM
Jan 7, 2025 09:15AM
Dec 19, 2024 09:15AM
Dec 17, 2024 09:00AM Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually
Sep 11, 2024 09:21AM
Sep 11, 2024 09:15AM
Sep 3, 2024 09:00AM
Jul 29, 2024 09:24AM
Jul 29, 2024 09:20AM
Jul 16, 2024 09:07AM
Jul 16, 2024 09:00AM Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
May 29, 2024 09:26AM
May 29, 2024 09:00AM
May 21, 2024 09:27AM
May 21, 2024 09:15AM
May 14, 2024 09:17AM
May 14, 2024 09:15AM
May 14, 2024 07:00AM Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
Apr 23, 2024 09:19AM
Apr 23, 2024 09:15AM
Apr 16, 2024 09:18AM
Apr 16, 2024 09:15AM
Apr 2, 2024 09:18AM
Apr 2, 2024 09:15AM
Mar 19, 2024 09:02AM Petros Pharmaceuticals (PTPI) Successfully Launches AI Tool
Mar 19, 2024 09:00AM
Feb 14, 2024 09:32AM
Feb 14, 2024 09:15AM
Jan 24, 2024 09:21AM
Jan 24, 2024 09:15AM
Jan 17, 2024 09:03AM
Jan 17, 2024 09:00AM Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
Dec 12, 2023 01:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All